As Teva proceeds down the more muted growth path that it telegraphed early this year, the generics and innovative medicines ...

A favorable regulatory resolution with federal health authorities is clearing the way for Incyte’s Opzelura cream to reach ...

Consider it a new supercharged player in the AI marketing game. Rare disease-focused pharma marketing agency CG Life is diving headfirst into the AI realm with the acquisition of AI-native agency The ...

The U.K. pharma marketing watchdog has slammed AGB Pharma for misleadingly implying a lack of fertility considerations for ...

It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia unanimously rejected (PDF) a challenge by Novartis on the legality of the Inflation ...

Even though Hengrui Pharma has resolved the manufacturing problems cited in a recent FDA complete response letter, a second ...

The three-year initiative is designed to generate 1.9 billion pound sterling ($2.5 billion) in annual cost savings by 2029, against 2.4 billion pound sterling in total one-time costs.  The cost ...

J&J has proposed a $5.5 billion settlement that could resolve roughly 76,000 multi-district litigation and state-level ...

Baxter International has issued a voluntary recall of one lot of cefazolin in dextrose injection after a report that ...

Havas Lynx has shaken up the leadership of its New York team, expanding Claire Knapp’s role to cover the office and hiring ...

In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...

The FDA has approved Otsuka Pharmaceutical’s once-daily extended-release capsule Simtriyo (centanafadine) f | Approval of the ...